Literature DB >> 2902678

[Two cases of psychotic state following normal-dose benzodiazepine withdrawal].

T Terao1, Y Tani.   

Abstract

We report two cases of severe withdrawal symptoms after abrupt discontinuation of a long-term normal-dose benzodiazepines (BZD) administration. Case 1, a 61-year-old man, suffered from delirium on the 7th day after abrupt discontinuation of nitrazepam, 10 mg/day. Case 2, a 49-year-old woman, suffered from auditory hallucination on the 4th day and visual cognitive disorder on the 5th day after abrupt discontinuation of nitrazepam, 5 mg/day, and triazolam, 0.5 mg/day. A withdrawal syndrome after discontinuation of normal-dose BZD is uncommon, and a psychotic withdrawal reaction is even more uncommon. We show how a continuous administration of BZD for a period of longer than 6 months and the presence of severe insomnia are risk factors predictive of a psychotic reaction. We also explain the predictive method used to determine the onset time of such a severe state. In the case of a psychotic state, we recommend intravenous diazepam injection. To prevent withdrawal reaction, we also recommend a gradual reduction after administration of normal-dose BZD.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2902678     DOI: 10.7888/juoeh.10.337

Source DB:  PubMed          Journal:  J UOEH        ISSN: 0387-821X


  3 in total

1.  Abrupt discontinuation of psychotropic drugs during pregnancy: fear of teratogenic risk and impact of counselling.

Authors:  A Einarson; P Selby; G Koren
Journal:  J Psychiatry Neurosci       Date:  2001-01       Impact factor: 6.186

2.  Discontinuing antidepressants and benzodiazepines upon becoming pregnant. Beware of the risks of abrupt discontinuation.

Authors:  A Einarson; P Selby; G Koren
Journal:  Can Fam Physician       Date:  2001-03       Impact factor: 3.275

3.  Psychiatric side effects of medications prescribed in internal medicine.

Authors:  Rodrigo Casagrande Tango
Journal:  Dialogues Clin Neurosci       Date:  2003-06       Impact factor: 5.986

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.